Stericycle price target lowered to $55 from $62 at Baird

Baird analyst David Manthey lowered the firm’s price target on Stericycle to $55 from $62 and keeps a Neutral rating on the shares. The firm said management announced a new subscription-based SID service offering which seems to have potential. Overall, while acknowledging the attractive long-term improvement opportunity, Baird is staying on the sidelines during the early post-ERP deployment period.